Please be informed project submission for the "Gilead Cell Therapy Grants 2023" is now open!
The Belgian Hematology Society (BHS), with the support of an unrestricted grant from Gilead Sciences and Kite, a Gilead company, has the pleasure to announce two grants to support research in the field of cellular therapies in hematological disease.
Researchers working in hematology are invited to submit their projects and apply for the Gilead Cell Therapy Grants. All information on rules and regulations are available on the homepage, as is the application form. The deadline for submission is on Thursday, 1 December 2022, at midnight CET. Extended to Monday, 12 December 2022, at midnight CET.
The jury will select two winning projects based on their innovative character, which will be awarded with EUR 25.000 per project. The award ceremony will take place at the 38th BHS General Annual Meeting, February 3-4, 2023.
We are looking forward to receiving outstanding projects that can advance the outcomes of hematological diseases through cellular therapies.
Sincerely,
Marc André, President of the BHS